Julia Fehniger

541 total citations
25 papers, 397 citations indexed

About

Julia Fehniger is a scholar working on Oncology, Genetics and Reproductive Medicine. According to data from OpenAlex, Julia Fehniger has authored 25 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Genetics and 7 papers in Reproductive Medicine. Recurrent topics in Julia Fehniger's work include BRCA gene mutations in cancer (8 papers), Ovarian cancer diagnosis and treatment (7 papers) and COVID-19 and healthcare impacts (5 papers). Julia Fehniger is often cited by papers focused on BRCA gene mutations in cancer (8 papers), Ovarian cancer diagnosis and treatment (7 papers) and COVID-19 and healthcare impacts (5 papers). Julia Fehniger collaborates with scholars based in United States. Julia Fehniger's co-authors include Mary Beattie, Celia P. Kaplan, Feng Lin, Galen Joseph, Douglas A. Levine, Bhavana Pothuri, Petar Jelinic, Jennifer M. Creasman, S. Diane Yamada and Chuanhong Liao and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Obstetrics and Gynecology.

In The Last Decade

Julia Fehniger

24 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia Fehniger United States 11 158 134 71 47 43 25 397
Steinar Nilssen Norway 11 83 0.5× 97 0.7× 141 2.0× 106 2.3× 55 1.3× 15 527
Anthony Proietto Australia 16 80 0.5× 155 1.2× 164 2.3× 106 2.3× 40 0.9× 41 671
Huong Meeks United States 11 58 0.4× 39 0.3× 57 0.8× 53 1.1× 27 0.6× 53 550
Tia L. Kauffman United States 17 220 1.4× 169 1.3× 22 0.3× 127 2.7× 62 1.4× 51 680
Cecilie Dyg Sperling Denmark 14 25 0.2× 166 1.2× 77 1.1× 60 1.3× 33 0.8× 24 419
Sean Burns United States 8 42 0.3× 99 0.7× 24 0.3× 64 1.4× 21 0.5× 9 387
Kyle E. Freese United States 8 27 0.2× 134 1.0× 66 0.9× 26 0.6× 69 1.6× 13 420
Hislop Tg Canada 10 30 0.2× 209 1.6× 138 1.9× 60 1.3× 101 2.3× 13 433
Anne Van Arsdale United States 12 34 0.2× 183 1.4× 121 1.7× 126 2.7× 51 1.2× 25 588
Anita WW Lim United Kingdom 12 29 0.2× 231 1.7× 62 0.9× 111 2.4× 229 5.3× 26 466

Countries citing papers authored by Julia Fehniger

Since Specialization
Citations

This map shows the geographic impact of Julia Fehniger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Fehniger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Fehniger more than expected).

Fields of papers citing papers by Julia Fehniger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Fehniger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Fehniger. The network helps show where Julia Fehniger may publish in the future.

Co-authorship network of co-authors of Julia Fehniger

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Fehniger. A scholar is included among the top collaborators of Julia Fehniger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Fehniger. Julia Fehniger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levitan, Daniel, et al.. (2022). Cutaneous metastasis of PD-L1 positive cervical carcinoma. Gynecologic Oncology Reports. 41. 101003–101003. 2 indexed citations
2.
Lara, Olivia D., Yuyan Wang, Roisin E. O’Cearbhaill, et al.. (2021). COVID-19 outcomes of patients with gynecologic cancer in New York City: An updated analysis from the initial surge of the pandemic. Gynecologic Oncology. 164(2). 304–310. 8 indexed citations
3.
Lara, Olivia D., Yuyan Wang, Roisin E. O’Cearbhaill, et al.. (2021). COVID-19 outcomes of patients with gynecologic cancer in New York City: an updated analysis. Gynecologic Oncology. 162. S22–S23. 1 indexed citations
4.
Lara, Olivia D., Roisin E. O’Cearbhaill, Anne Knisely, et al.. (2020). Inflammatory markers in gynecologic oncology patients hospitalized with COVID-19 infection. Gynecologic Oncology. 159(3). 618–622. 9 indexed citations
5.
Fehniger, Julia, et al.. (2020). Endometrial adenocarcinoma presenting as a suprasellar mass: lessons to be learned. ecancermedicalscience. 14. 1083–1083.
6.
Fehniger, Julia, Douglas A. Levine, & Bhavana Pothuri. (2020). BRCA 1/2 Somatic Mutations in Patients with Advanced or Recurrent Endometrial Cancer. Gynecologic Oncology. 158(1). e16–e16. 2 indexed citations
7.
Lara, Olivia D., Yuyan Wang, Roisin E. O’Cearbhaill, et al.. (2020). Racial disparities in patients with coronavirus disease 2019 infection and gynecologic malignancy. Cancer. 127(7). 1057–1067. 7 indexed citations
8.
Fehniger, Julia, et al.. (2019). Comprehensive genomic sequencing of paired ovarian cancers reveals discordance in genes that determine clinical trial eligibility. Gynecologic Oncology. 155(3). 473–482. 3 indexed citations
10.
Fehniger, Julia, et al.. (2018). Small cell cancers of the female genital tract: Molecular and clinical aspects. Gynecologic Oncology. 149(2). 420–427. 38 indexed citations
11.
Lee, Jessica, Julia Fehniger, Douglas A. Levine, et al.. (2018). Missed opportunities: Genetic counseling and testing among an ethnically diverse cohort of women with endometrial cancer. Gynecologic Oncology. 151(1). 153–158. 22 indexed citations
12.
Olsen, Anne O., et al.. (2018). Assessing delay and barriers to risk-reducing surgery in women with BRCA mutations.. Journal of Clinical Oncology. 36(15_suppl). 5564–5564. 1 indexed citations
13.
Fehniger, Julia, Amnon A. Berger, Laurie M. Gay, et al.. (2018). Genomic mutation profiles of paired ovarian cancers (OC) across time.. Journal of Clinical Oncology. 36(15_suppl). 5521–5521. 1 indexed citations
14.
Mills, Kathryn, Julia Fehniger, Chuanhong Liao, et al.. (2017). Venous Thromboembolism in Patients Receiving Extended Pharmacologic Prophylaxis After Robotic Surgery for Endometrial Cancer. International Journal of Gynecological Cancer. 27(8). 1774–1782. 19 indexed citations
15.
Fehniger, Julia, Stephen Thomas, Ernst Lengyel, et al.. (2016). A prospective study evaluating diffusion weighted magnetic resonance imaging (DW-MRI) in the detection of peritoneal carcinomatosis in suspected gynecologic malignancies. Gynecologic Oncology. 142(1). 169–175. 36 indexed citations
16.
Fehniger, Julia, Jeanette S. Brown, Jennifer M. Creasman, et al.. (2013). Childbirth and Female Sexual Function Later in Life. Obstetrics and Gynecology. 122(5). 988–997. 25 indexed citations
17.
Fehniger, Julia, Jennifer Livaudais‐Toman, Leah Karliner, et al.. (2013). Perceived Versus Objective Breast Cancer Risk in Diverse Women. Journal of Women s Health. 23(5). 420–427. 31 indexed citations
18.
Kardashian, Ani, et al.. (2012). A Pilot study of the Sharing Risk Information Tool (ShaRIT) for Families with Hereditary Breast and Ovarian Cancer Syndrome. Hereditary Cancer in Clinical Practice. 10(1). 4–4. 28 indexed citations
19.
Mannis, Gabriel N., et al.. (2012). Risk-Reducing Salpingo-oophorectomy and Ovarian Cancer Screening in 1077 Women After BRCA Testing. JAMA Internal Medicine. 173(2). 96–96. 21 indexed citations
20.
Fehniger, Julia, et al.. (2012). Peritoneal cytology in risk-reducing salpingo-oophorectomy: Implications for cancer outcomes. Gynecologic Oncology. 127(1). S17–S17. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026